Report error Found 25 of ic50 data for polymerid = 50004779
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 80nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 130nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 150nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 340nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 600nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 900nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.35E+3nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 9.00E+3nMAssay Description:Antagonist activity at Escherichia coli UT189 FimH in guinea pig red blood cells assessed as disaggregation of bacteria after 600 secs by aggregometr...More data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at Escherichia coli UT189 FimH in guinea pig red blood cells assessed as disaggregation of bacteria after 600 secs by aggregometr...More data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.40E+4nMAssay Description:Antagonist activity at Escherichia coli UT189 FimH in guinea pig red blood cells assessed as disaggregation of bacteria after 600 secs by aggregometr...More data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.70E+4nMAssay Description:Antagonist activity at Escherichia coli UT189 FimH in guinea pig red blood cells assessed as disaggregation of bacteria after 600 secs by aggregometr...More data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 3.10E+4nMAssay Description:Antagonist activity at Escherichia coli UT189 FimH in guinea pig red blood cells assessed as disaggregation of bacteria after 600 secs by aggregometr...More data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 3.30E+4nMAssay Description:Antagonist activity at Escherichia coli UT189 FimH in guinea pig red blood cells assessed as disaggregation of bacteria after 600 secs by aggregometr...More data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 3.80E+4nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 4.10E+4nMAssay Description:Antagonist activity at Escherichia coli UT189 FimH in guinea pig red blood cells assessed as disaggregation of bacteria after 600 secs by aggregometr...More data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 4.20E+4nMAssay Description:Antagonist activity at Escherichia coli UT189 FimH in guinea pig red blood cells assessed as disaggregation of bacteria after 600 secs by aggregometr...More data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 4.50E+4nMAssay Description:Antagonist activity at Escherichia coli UT189 FimH in guinea pig red blood cells assessed as disaggregation of bacteria after 600 secs by aggregometr...More data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 4.50E+4nMAssay Description:Antagonist activity at Escherichia coli UT189 FimH in guinea pig red blood cells assessed as disaggregation of bacteria after 600 secs by aggregometr...More data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics
Curated by ChEMBL
Fimbrion Therapeutics
Curated by ChEMBL
Affinity DataIC50: 7.71E+4nMAssay Description:Antagonist activity at Escherichia coli UT189 FimH in guinea pig red blood cells assessed as disaggregation of bacteria after 600 secs by aggregometr...More data for this Ligand-Target Pair
